Home >> General Pharmaceuticals >> Housing >> Food & Beverage >>

Age Related Memory Impairment - Pipeline Review, H2 2014

Published: Dec-2014 | Format: PDF | Global Markets Direct | Number of pages: 34 | Code: MRS - 3081

 

Global Markets Directs, Age Related Memory Impairment Pipeline Review, H2 2014, provides an overview of the Age Related Memory Impairments therapeutic pipeline.


This report provides comprehensive information on the therapeutic development for Age Related Memory Impairment, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Age Related Memory Impairment and special features on late-stage and discontinued projects.


Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.


The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.


Scope


The report provides a snapshot of the global therapeutic landscape of Age Related Memory Impairment
The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
The report reviews key players involved in the therapeutics development for Age Related Memory Impairment and enlists all their major and minor projects
The report summarizes all the dormant and discontinued pipeline projects
A review of the Age Related Memory Impairment products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
A detailed assessment of monotherapy and combination therapy pipeline projects
Coverage of the Age Related Memory Impairment pipeline on the basis of target, MoA, route of administration and molecule type
Latest news and deals relating related to pipeline products


Reasons to buy


Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop strategic initiatives by understanding the focus areas of leading companies
Identify and understand important and diverse types of therapeutics under development for Age Related Memory Impairment
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Devise corrective measures for pipeline projects by understanding Age Related Memory Impairment pipeline depth and focus of Indication therapeutics
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Table of Contents
 

Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Age Related Memory Impairment Overview 6
Therapeutics Development 7
Pipeline Products for Age Related Memory Impairment - Overview 7
Pipeline Products for Age Related Memory Impairment - Comparative Analysis 8
Age Related Memory Impairment - Therapeutics under Development by Companies 9
Age Related Memory Impairment - Pipeline Products Glance 10
Clinical Stage Products 10
Early Stage Products 11
Age Related Memory Impairment - Products under Development by Companies 12
Age Related Memory Impairment - Companies Involved in Therapeutics Development 13
Calico LLC 13
Dart NeuroScience LLC 14
Pharnext SAS 15
Age Related Memory Impairment - Therapeutics Assessment 16
Assessment by Monotherapy Products 16
Assessment by Target 17
Assessment by Mechanism of Action 19
Assessment by Route of Administration 21
Assessment by Molecule Type 22
Drug Profiles 24
HT-0712 - Drug Profile 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
P7-C3A20 - Drug Profile 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
PXT-864 - Drug Profile 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
rhTFAM for Sepsis and Cognitive Disorders - Drug Profile 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
Small Molecules to Activate NAMPT for Neurological Disorders - Drug Profile 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
Age Related Memory Impairment - Recent Pipeline Updates 31
Age Related Memory Impairment - Dormant Projects 32
Appendix 33
Methodology 33
Coverage 33
Secondary Research 33
Primary Research 33
Expert Panel Validation 33
Contact Us 34
Disclaimer 34

 

List of Tables
 

Number of Products under Development for Age Related Memory Impairment, H2 2014 7
Number of Products under Development for Age Related Memory Impairment - Comparative Analysis, H2 2014 8
Number of Products under Development by Companies, H2 2014 9
Comparative Analysis by Clinical Stage Development, H2 2014 10
Comparative Analysis by Early Stage Development, H2 2014 11
Products under Development by Companies, H2 2014 12
Age Related Memory Impairment - Pipeline by Calico LLC, H2 2014 13
Age Related Memory Impairment - Pipeline by Dart NeuroScience LLC, H2 2014 14
Age Related Memory Impairment - Pipeline by Pharnext SAS, H2 2014 15
Assessment by Monotherapy Products, H2 2014 16
Number of Products by Stage and Target, H2 2014 18
Number of Products by Stage and Mechanism of Action, H2 2014 20
Number of Products by Stage and Route of Administration, H2 2014 21
Number of Products by Stage and Molecule Type, H2 2014 23
Age Related Memory Impairment Therapeutics - Recent Pipeline Updates, H2 2014 31
Age Related Memory Impairment - Dormant Projects, H2 2014 32

 

List of Figures
 

Number of Products under Development for Age Related Memory Impairment, H2 2014 7
Number of Products under Development for Age Related Memory Impairment - Comparative Analysis, H2 2014 8
Number of Products under Development by Companies, H2 2014 9
Assessment by Monotherapy Products, H2 2014 16
Number of Products by Top 10 Targets, H2 2014 17
Number of Products by Stage and Top 10 Targets, H2 2014 18
Number of Products by Top 10 Mechanism of Actions, H2 2014 19
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2014 20
Number of Products by Top 10 Molecule Types, H2 2014 22
Number of Products by Stage and Top 10 Molecule Types, H2 2014 23

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)2000 View Pricing